BNP Paribas Financial Markets
SER icon

BNP Paribas Financial Markets’s Serina Therapeutics SER Stock Holding History

BNP Paribas Financial Markets’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
2
– – ﹤0.01% 5884
2026
Q1 		$4 Hold
2
– – ﹤0.01% 5784
2025
Q4 		$4 Hold
2
– – ﹤0.01% 5714
2025
Q3 		$11 Hold
2
– – ﹤0.01% 5518
2025
Q2 		$12 Hold
2
– – ﹤0.01% 5405
2025
Q1 		$11 Hold
2
– – ﹤0.01% 5337
2024
Q4 		$10 Hold
2
– – ﹤0.01% 5361
2024
Q3 		$13 Hold
2
– – ﹤0.01% 4113
2024
Q2 		$19 Hold
2
– – ﹤0.01% 4008
2024
Q1 		$27 Hold
2
– – ﹤0.01% 3995
2023
Q4 		$28 Hold
2
– – ﹤0.01% 3974
2023
Q3 		$50 Hold
2
– – ﹤0.01% 3868
2023
Q2 		$66 Hold
2
– – ﹤0.01% 3868
2023
Q1 		$49 Sell
2
-7
-78% -$161 ﹤0.01% 3795
2022
Q4 		$184 Hold
9
– – ﹤0.01% 3928
2022
Q3 		$188 Hold
9
– – ﹤0.01% 4616
2022
Q2 		$192 Sell
9
-9
-50% -$243 ﹤0.01% 3996
2022
Q1 		$541 Hold
18
– – ﹤0.01% 4014
2021
Q4 		$691 Hold
18
– – ﹤0.01% 4086
2021
Q3 		$596 Hold
18
– – ﹤0.01% 3919
2021
Q2 		$983 Hold
18
– – ﹤0.01% 3947
2021
Q1 		$1.03K Hold
18
– – ﹤0.01% 3926
2020
Q4 		$964 Sell
18
-110
-86% -$6.34K ﹤0.01% 4027
2020
Q3 		$3.65K Sell
128
-82
-39% -$2.93K ﹤0.01% 4031
2020
Q2 		$7K Sell
210
-27
-11% -$795 ﹤0.01% 3866
2020
Q1 		$7.75K Buy
237
+155
+189% +$7.29K ﹤0.01% 4046
2019
Q4 		$5.26K Buy
82
+19
+30% +$1.03K ﹤0.01% 4185
2019
Q3 		$4.34K Buy
63
+29
+85% +$2.75K ﹤0.01% 4288
2019
Q2 		$4.44K Buy
+34
New +$4.6K ﹤0.01% 4256

Other funds holding SER

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets's SER Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Serina Therapeutics (SER) position steady in Q2 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5884.

BNP Paribas Financial Markets first reported a position in SER in Q2 2019 and has held it in 29 quarters since. The position peaked at $7.75K in Q1 2020. 21 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • BNP Paribas Financial Markets held 2 shares of Serina Therapeutics worth $4 as of Q2 2026.
  • BNP Paribas Financial Markets left its Serina Therapeutics share count unchanged in Q2 2026.
  • Serina Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5884 holding.
  • BNP Paribas Financial Markets first reported a position in Serina Therapeutics in Q2 2019 and has held it in 29 quarters since.
  • BNP Paribas Financial Markets's Serina Therapeutics position peaked at $7.75K in Q1 2020.
  • 21 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.